Idiopathic Pulmonary Fibrosis

ASP0165 Galapagos Idiopathic Pulmonary Fibrosis_Flyer_NZ_English_v1_05Oct2018

Living with idiopathic pulmonary fibrosis (IPF)?

Find out if the Isabela study is right for you.

Right now, the ISABELA clinical research study is testing a

medication in people with idiopathic pulmonary fibrosis. If you

take part in this study, you’ll receive study medication or a placebo

on top of your standard of care treatment. The study medication

is provided at no cost.

Study participants will receive:

• Study medication

• Study-related medical care

• Reimbursement for expenses

You may qualify to participate if you are:

• 40 years of age or older

• Diagnosed with pulmonary idiopathic fibrosis (IPF)

• In stable condition

Talk to your doctor or nurse about the ISABELA clinical study.

Contact Carol or Mel at 09 6385255 Ext 212 or email carol@nzrsi.health.nz

Living